Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Blood|May 16, 2002
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivoMark Levis, Jeffrey Allebach, Kam-Fai Tse, et al.Journal of the National Cancer Institute|January 31, 2008
Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemiaWeiguo Zhang, Marina Konopleva, Yue-xi Shi, et al.Biorxiv : the Preprint Server for Biology|December 4, 2025
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with <i>NRAS</i> mutations to FLT3 inhibitorsAditi Chatterjee, Moaath K Mustafa Ali, Christopher M Bailey, et al.Leukemia|June 2, 2026
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitorsAditi Chatterjee, Moaath K Mustafa Ali, Christopher M Bailey, et al.Cancer Research|July 26, 2014
FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemiaHayley S Ma, Bao Nguyen, Amy S Duffield, et al.Genes, Chromosomes & Cancer|August 14, 2019
A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumorPedram Argani, Lei Zhang, Yun-Shao Sung, et al.Blood|November 26, 2008
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical responseKeith W Pratz, Jorge Cortes, Gail J Roboz, et al.American Journal of Clinical Pathology|April 24, 2012
Flow cytometric findings in hemophagocytic lymphohistiocytosisChad M McCall, Shiyama Mudali, Robert J Arceci, et al.Blood|September 13, 2003
FLT3 ligand causes autocrine signaling in acute myeloid leukemia cellsRui Zheng, Mark Levis, Obdulio Piloto, et al.Cancer Research|September 20, 2017
Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other MalignanciesJ Kyle Bruner, Hayley S Ma, Li Li, et al.Pageof 9